ArticlePsychotherapy and psychosomatics2026
The Impact of Trauma-Focused Cognitive Behavior Therapy for Psychosis on Post-Traumatic Stress Symptoms in Daily Life: Experience Sampling Methodology Outcomes of the STAR Trial.
Article in Psychotherapy and psychosomatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPeople with psychosis have high rates of post-traumatic stress disorder (PTSD). The Study of Trauma And Recovery (STAR) randomized controlled trial found that a trauma-focused cognitive behavior therapy for psychosis (TF-CBTp) added to treatment-as-usual (TAU) reduced PTSD symptoms in people with psychosis compared to TAU only. We hypothesized that TF-CBTp would also reduce PTSD symptoms in daily life, using experience sampling methodology (ESM), which would be associated with improvements on a clinical measure of PTSD.
methodsParticipants were adults with PTSD and schizophrenia spectrum diagnoses, a subsample of the STAR trial (N = 153; TF-CBTp+TAU = 73, TAU = 80). Participants completed ESM assessments of intrusive memories, hyperarousal, dissociation, avoidance, and negative trauma-related cognitions through a smartphone app multiple times daily over 6 days, at baseline and 9 months post-randomization (end of therapy).
resultsNo between-group differences were found in ESM measures of momentary PTSD symptoms at 9 months. Significant timepoint × therapy interactions indicated greater decrease over time in hyperarousal, negative cognitions, and avoidance, and in variability of intrusive memories, in TF-CBTp+TAU compared to TAU. ESM measures at 9 months were significantly associated with improvements on the Clinician-Administered PTSD Scale for DSM-5.
conclusionWhile findings are tentatively in favor of TF-CBTp, the robust reductions in PTSD symptoms found in the STAR trial using retrospective outcome measures were not fully replicated with ESM, suggesting these methodologies may be capturing different features of symptom expression and processes of therapeutic change. Including both approaches in future research could provide a fuller picture of therapy effects on "in-the-moment" versus reflective reports of experiences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.